In this study, we analyzed a large number of 10,000 patients with advanced cancers for oncogenic mutations in EGFR, ERBB2, BRAF, and MAP2K1, especially for those located within the kinase domain β3‐αC loop. The gene discussed is ERBB2; the disease is cancer.